Undergraduate Pharmacology: Drug Interactions - Vocabulary Flashcards

0.0(0)
studied byStudied by 0 people
0.0(0)
full-widthCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/46

flashcard set

Earn XP

Description and Tags

Vocabulary flashcards covering key terms and concepts from the Drug Interactions lecture notes.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

47 Terms

1
New cards

Drug interaction

Pharmacological or clinical response to a drug combination that differs from the expected effects of the two drugs given alone; includes antagonism and synergism.

2
New cards

Antagonism

A drug interaction where the combined effect is less than the sum of the effects of each drug given alone.

3
New cards

Synergism

A drug interaction where the combined effect is greater than the sum of the individual effects.

4
New cards

Pharmacokinetic interaction

An interaction in which one drug changes the absorption, distribution, metabolism, or excretion of another, altering its plasma concentration.

5
New cards

Pharmacodynamic interaction

An interaction where one drug changes a patient’s response to another drug without changing the kinetics of the second drug.

6
New cards

Pharmaceutical interaction

Physical or chemical incompatibilities between drugs (e.g., IV admixtures).

7
New cards

Drug-food interaction

Interactions between drugs and foods or other non-drug substances (enteral products, nutrients, alcohol, tobacco) affecting absorption or effect.

8
New cards

Enteral products

Foods or nutrients administered through the GI tract that can interact with drugs.

9
New cards

Narrow therapeutic range

Drugs with a small margin between therapeutic and toxic doses (e.g., digoxin, theophylline).

10
New cards

Steep dose–response curve

Small changes in dose produce large changes in effect (e.g., phenytoin, aminoglycosides).

11
New cards

Object drugs

Drugs with a narrow therapeutic range, a steep dose–response, hepatic metabolism, and typically used chronically.

12
New cards

Complexation

Mechanism where two drugs form a chemical complex, reducing absorption (e.g., with cholestyramine or metal ions in antacids).

13
New cards

Bile acid resins

Cholestyramine and colestipol; form complexes that lower absorption of other drugs.

14
New cards

Metal ions in interfering products

Divalent/trivalent ions (Mg2+, Ca2+, Zn2+, Fe2+/Fe3+, Al3+) in antacids/multivitamins that chelate drugs and reduce absorption.

15
New cards

Changes in pH (absorption)

Drug-induced pH changes that alter dissolution and absorption; examples include H2 blockers, PPIs, and antacids.

16
New cards

H2 receptor blockers

Cimetidine and ranitidine; raise gastric pH and can reduce absorption of acid-dependent drugs.

17
New cards

Proton pump inhibitors

Omeprazole and lansoprazole; raise gastric pH, affecting dissolution of some drugs.

18
New cards

Antacids

Alkaline preparations that raise gastric pH and can affect dissolution of certain drugs.

19
New cards

Drugs needing acid pH for dissolution

Drugs that require acidic conditions to dissolve (e.g., ketoconazole, itraconazole, iron supplements).

20
New cards

Changes in GI motility

Drugs that slow (e.g., opioids, anticholinergics; antihistamines, TCAs, phenothiazines) or speed (e.g., laxatives, metoclopramide, erythromycin) GI transit, altering absorption.

21
New cards

Opioids (GI effect)

Drugs that slow GI motility, potentially delaying absorption.

22
New cards

Erythromycin (GI effect)

A macrolide that can speed GI motility, altering absorption of concomitant drugs.

23
New cards

Absorption (drug interactions)

Pharmacokinetic interactions that change the extent or rate of drug absorption.

24
New cards

Cytochrome P‑450 (CYP450)

A family of enzymes responsible for drug metabolism; major isoforms include CYP1A2, CYP2C9, CYP2C19, CYP2D6, CYP3A4/3A3.

25
New cards

CYP2D6 polymorphism

Genetic variation leading to poor, intermediate, extensive, or ultrarapid metabolism; ~25% of clinically used drugs metabolized by CYP2D6.

26
New cards

Poor metabolizer

Individual with very low CYP2D6 activity, leading to slower drug metabolism.

27
New cards

Ultrarapid metabolizer

Individual with high CYP2D6 activity, leading to faster drug metabolism.

28
New cards

Factors affecting metabolism: age (very young)

In neonates, glucuronidation is immature (Gray Baby syndrome) due to deficient Phase-2 enzymes.

29
New cards

Factors affecting metabolism: elderly

Reduced metabolism and excretion; more drugs used concurrently; dosing escalation often needed.

30
New cards

Disease state effect on metabolism

Liver diseases (hepatitis, hepatic cancer) reduce drug clearance and increase overdose risk.

31
New cards

Enzyme induction

Drugs that increase hepatic metabolic enzyme levels, increasing metabolism of substrates; onset days to weeks; offset weeks after stopping.

32
New cards

Enzyme inducers

Examples include barbiturates, phenytoin, primidone, carbamazepine, rifampin, ritonavir, plus cigarette smoking, chronic alcohol use, charbroiled meat.

33
New cards

Time course of induction

Induction onset ~5 days; maximum ~2 weeks; offset 3+ weeks after stopping.

34
New cards

Enzyme inhibition

Drugs that decrease CYP enzyme activity, increasing substrate concentrations and effects.

35
New cards

Time course of inhibition

Inhibition often rapid; maximal within 24 hours; offset usually within 24 hours after discontinuation.

36
New cards

Important enzyme inhibitors

Amiodarone, cimetidine, ciprofloxacin, clarithromycin, diltiazem, fluoxetine, ketoconazole, lovastatin, metoclopramide, omeprazole, SMX/TMP, sertraline, verapamil, ticlopidine.

37
New cards

Pharmacodynamic interaction

Effect of one drug on the concentration–effect relationship of another drug without pharmacokinetic changes.

38
New cards

Antagonistic pharmacodynamic interactions

One drug reduces or blocks the effect of another (example: cholinergic antagonist diminishing cholinergic therapy).

39
New cards

Synergistic/additive pharmacodynamic effects

Combined effects that are greater (or more adverse) than either drug alone.

40
New cards

Additive CNS depressant effects

Combined sedation from alcohol, analgesics, antihistamines, barbiturates, benzodiazepines, beta-blockers, anticonvulsants, sedatives, phenothiazines, TCAs, anesthetics, muscle relaxants.

41
New cards

Additive anticholinergic effects

Cumulative antimuscarinic effects from multiple drugs (e.g., haloperidol, amitriptyline, benztropine, scopolamine, dicyclomine, diphenhydramine, benzodiazepines).

42
New cards

Antagonistic example

Cholinergic and anticholinergic drugs (e.g., donepezil with tolterodine) may worsen urinary incontinence through opposing actions.

43
New cards

Herbs and drug interactions: Ginseng

Ginseng can increase INR when taken with warfarin.

44
New cards

Herbs and drug interactions: Garlic

Garlic has antiplatelet effects; interactions with aspirin, warfarin, ticlopidine, clopidogrel, dipyridamole.

45
New cards

Herbs and drug interactions: Ginkgo biloba

Ginkgo has antiplatelet effects; interactions with aspirin, warfarin, ticlopidine, clopidogrel, dipyridamole.

46
New cards

Herbs and drug interactions: Ginger

Ginger can potentiate anticoagulants (e.g., warfarin) via thromboxane pathway effects.

47
New cards

Herbs and drug interactions: St. John’s Wort

Herbal that can induce CYP enzymes and affect MAOI/SSRI interactions; can reduce levels of many drugs.